Clinical Study of AL2846 Capsule in the Treatment of Differentiated Thyroid Cancer
Clinical trial NCT05745363 · COMPLETED
Trial details
- NCT number
- NCT05745363
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-24
- Primary completion
- 2025-11-13
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.